# Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet

> **NCT00541437** · — · COMPLETED · sponsor: **Genovate Biotechnology Co., Ltd.,** · enrollment: 12 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00541437
- **Lead sponsor:** Genovate Biotechnology Co., Ltd.,
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** 2007-02
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2007-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00541437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00541437, "Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00541437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*